General Information of the Compound
| Compound ID |
CP0952667
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(3'-(imidazolyl-5''-yl)propanamido]morphinan
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H32N4O4
|
||||||||||||||||||
| Molecular Weight |
464.566
|
||||||||||||||||||
| Canonical SMILES |
O=C(CCc1cnc[nH]1)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H32N4O4/c31-19-5-3-16-11-20-26(33)8-7-18(29-21(32)6-4-17-12-27-14-28-17)24-25(26,22(16)23(19)34-24)9-10-30(20)13-15-1-2-15/h3,5,12,14-15,18,20,24,31,33H,1-2,4,6-11,13H2,(H,27,28)(H,29,32)/t18-,20-,24+,25+,26-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OGWLXTVCBCGRKS-HFXSLSFNSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02264, Kappa-type opioid receptor
Protein ID: PT02699, Mu-type opioid receptor